ea0029p1122 | Neuroendocrinology | ICEECE2012
Albertelli M.
, Grillo F.
, Giannone A.
, Mastracci L.
, Annunziata F.
, Arvigo M.
, Minuto F.
, Fiocca R.
, Ferone D.
Gastroenteropancreatic (GEP) neuroendocrine tumours (NETs) are rare neoplasms with heterogeneous clinical behavior and potential long-term survival. In the last decade GEPNET nomenclature has been twice reviewed. However, the 2000 WHO classification had poor prognostic power in well differentiated (WD) neoplasms. This led to the introduction of two new important parameters by the European Neuroendocrine Tumors Society (ENETS), grade and stage; the former became part of t...